A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
In September, presented data on the long-term safety of ampreloxetine in nOH at the 2024 International Congress of Parkinson's Disease and Movement Disorders ®. Data indicate ampreloxetine was ...
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Sessions that focused on diagnosis and acute treatment of rare neuroimmune disorders (RNDs). A panel of people with these ...
University of Wisconsin-Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
Discover TD” gamified patient scenarios to help health care professionals accurately diagnose tardive dyskinesia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback